These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 26176919)

  • 1. Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.
    Vinayak S; Pawlowic MC; Sateriale A; Brooks CF; Studstill CJ; Bar-Peled Y; Cipriano MJ; Striepen B
    Nature; 2015 Jul; 523(7561):477-80. PubMed ID: 26176919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum.
    Choudhary HH; Nava MG; Gartlan BE; Rose S; Vinayak S
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843543
    [No Abstract]   [Full Text] [Related]  

  • 3. Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.
    Pawlowic MC; Vinayak S; Sateriale A; Brooks CF; Striepen B
    Curr Protoc Microbiol; 2017 Aug; 46():20B.2.1-20B.2.32. PubMed ID: 28800157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Manipulation of Cryptosporidium parvum with CRISPR/Cas9.
    Sateriale A; Pawlowic M; Vinayak S; Brooks C; Striepen B
    Methods Mol Biol; 2020; 2052():219-228. PubMed ID: 31452165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of INS15 in the development and pathogenicity of the zoonotic pathogen Cryptosporidium parvum.
    He W; Cui H; Li N; Guo Y; Zeng S; Feng Y; Xiao L; Xu R
    PLoS Negl Trop Dis; 2024 Oct; 18(10):e0012569. PubMed ID: 39361715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasitology: CRISPR for Cryptosporidium.
    Beverley SM
    Nature; 2015 Jul; 523(7561):413-4. PubMed ID: 26176915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Ablation of a Female-Specific Apetala 2 Transcription Factor Blocks Oocyst Shedding in Cryptosporidium parvum.
    Tandel J; Walzer KA; Byerly JH; Pinkston B; Beiting DP; Striepen B
    mBio; 2023 Apr; 14(2):e0326122. PubMed ID: 36786597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life cycle progression and sexual development of the apicomplexan parasite Cryptosporidium parvum.
    Tandel J; English ED; Sateriale A; Gullicksrud JA; Beiting DP; Sullivan MC; Pinkston B; Striepen B
    Nat Microbiol; 2019 Dec; 4(12):2226-2236. PubMed ID: 31477896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial genetics: C. parvum gets the CRISPR upgrade.
    Zuccala E
    Nat Rev Genet; 2015 Sep; 16(9):500. PubMed ID: 26239714
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental evidence for genetic recombination in the opportunistic pathogen Cryptosporidium parvum.
    Feng X; Rich SM; Tzipori S; Widmer G
    Mol Biochem Parasitol; 2002 Jan; 119(1):55-62. PubMed ID: 11755186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti].
    Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW
    Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
    Zhang X; Kim CY; Worthen T; Witola WH
    Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of Cryptosporidium growth in in vitro culture--the impact of parasite density on the success of infection.
    Paziewska-Harris A; Singer M; Schoone G; Schallig H
    Parasitol Res; 2016 Jan; 115(1):329-37. PubMed ID: 26435485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics meets transgenics in search of the elusive Cryptosporidium drug target.
    Striepen B; Kissinger JC
    Trends Parasitol; 2004 Aug; 20(8):355-8. PubMed ID: 15246316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru.
    Xiao L; Bern C; Limor J; Sulaiman I; Roberts J; Checkley W; Cabrera L; Gilman RH; Lal AA
    J Infect Dis; 2001 Feb; 183(3):492-7. PubMed ID: 11133382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.
    Edwinson A; Widmer G; McEvoy J
    Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunocompetent rat model of infection with Cryptosporidium hominis and Cryptosporidium parvum.
    Dayao DA; Sheoran A; Carvalho A; Xu H; Beamer G; Widmer G; Tzipori S
    Int J Parasitol; 2020 Jan; 50(1):19-22. PubMed ID: 31759945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apical Secretory Glycoprotein Complex Contributes to Cell Attachment and Entry by Cryptosporidium parvum.
    Akey ME; Xu R; Ravindran S; Funkhouser-Jones L; Sibley LD
    mBio; 2023 Feb; 14(1):e0306422. PubMed ID: 36722968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
    Nava MG; Calderón F; Fernández E; Ballell L; Bamborough P; Vinayak S
    Microbiol Spectr; 2023 Feb; 11(1):e0387422. PubMed ID: 36533912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.